A Pipeline of AMP-Powered Immunotherapies - Elicio
Our preclinical programs demonstrate the broad therapeutic potential of our AMP platform to treat challenging cancers, including mBRAF and mTP53-driven cancers.
Targeting mKRAS With ELI-002 Cancer Vaccine - Elicio
Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger …
Elicio Therapeutics Moves into Boston’s Seaport District and …
Mar 15, 2022 · In addition, the move will also allow for the continuing development of the Company’s TCR-T and infectious disease programs. “As someone who’s been with the …
Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 ...
Dec 12, 2024 · These include statements regarding Elicio’s planned clinical programs, including planned clinical trials, the potential of Elicio’s product candidates, the expected participation …
Elicio Therapeutics Announces Completion of Merger with Angion ...
Jun 1, 2023 · These include statements regarding Elicio’s planned clinical programs, including planned clinical trials and data presentations and the potential of Elicio’s product candidates.
Elicio Therapeutics Reports Robust T cell Responses Across Diverse …
1 day ago · These include statements regarding Elicio’s planned clinical programs, including the timing and outcome of planned clinical trials; the potential of Elicio’s product candidates, …
Elicio Therapeutics Receives $2.6 Million Grant from the Gastro ...
The grant will enable Elicio to pursue initial patient clinical assessment. “We’re pleased to have this additional funding from the GI Research Foundation for these two cancer vaccine …
Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P …
Dec 3, 2024 · These include statements regarding Elicio’s planned clinical programs, including planned clinical trials, the potential of Elicio’s product candidates, and other statements …
Elicio Therapeutics Announces First Patient Dosed in Randomized …
Jan 11, 2024 · These include statements regarding Elicio’s planned clinical programs, including planned clinical trials, the potential of Elicio’s product candidates, and other statements …
Elicio Therapeutics Reports Inducement Grants
These include statements regarding Elicio’s planned clinical programs and statements regarding management’s intentions, plans, beliefs, expectations or forecasts for the future, and …